Prophylactic effect of citalopram in unipolar, recurrent depression: Placebo-controlled study of maintenance therapy

British Journal of Psychiatry

Volumn 178, Issue APR., 2001, Pages 304-310

  Hochstrasser, B ^a   Isaksen, P M ^a   Koponen, H ^a   Lauritzen, L ^a   Mahnert, F A ^a   Rouillon, F ^a   Wade, A G ^a   Andersen, M ^a   Pedersen, S F ^a   De Swart, J C G ^a   Nil, R ^a  

^a Privatklinik ^*  (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CITALOPRAM; PLACEBO;

ADULT; AGED; ARTICLE; BACKACHE; BRONCHITIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG INDUCED DISEASE; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; FINANCIAL MANAGEMENT; HEADACHE; HUMAN; INSOMNIA; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; PAIN; PROPHYLAXIS; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; RECURRENT DISEASE; SOMNOLENCE; VERTIGO;

ADOLESCENT; ADULT; AGED; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; CITALOPRAM; DEPRESSIVE DISORDER; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; RECURRENCE; SEROTONIN UPTAKE INHIBITORS;

EID: 0035073343     PISSN: 00071250     EISSN: None     Source Type: Journal    
DOI: 10.1192/bjp.178.4.304     Document Type: Article

References (28)

1. Verlauf unipolar depressiver, bipolar manisch-depressiver und schizoaffektiver erkrankungen und psychosen. Ergebnisse einer prospektiven studie
2. Risikofaktoren für den verlauf affektiver störungen
3. Family history as a predictor of poor long-term outcome in depression
4. Dose-response efficacy of paroxetine in preventing depressive recurrences: A randomised, double-blind study
5. Three-year outcomes for maintenance therapies in recurrent depression
6. Conceptualisation and rationale for consensus definitions of terms in major depressive disorder
7. Comparison of full-dose versus half-dose pharmacotherapy in the maintenance treatment of recurrent depression
8. Exemplary data: Sample size and power in the design of event-time clinical trials
9. Implications of failing to achieve successful long-term maintenance treatment of recurrent unipolar major depression
10. Maintenance phase efficacy of sertraline for chronic depression
11. Recurrence in affective disorder. II. Effect of age and gender
12. The effect of episodes on recurrence in affective disorder: A case register study
13. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey
14. A new depression scale designed to be sensitive to change
15. The prophylactic efficacy of fluoxetine in unipolar depression
16. A 24-week study of 20 mg citalopram, 40 mg citalopram, and placebo in the prevention of relapse of major depression
17. Recurrence after recovery from major depressive disorder during 15 years of observational follow-up
18. Mood disorders: Pharmacologic prevention of recurrences
19. Citalopram. A review of its pharmacology, clinical efficacy, and tolerability in the treatment of depression
20. Nortriptyline and interpersonal psychotherapy as maintenance therapies for recurrent major depression: A randomized controlled trial in patients older than 59 years
21. Citalopram in doses of 20-60 mg is effective in depression relapse prevention: A placebo-controlled 6 month study
22. Selective serotonin reuptake inhibitor discontinuation syndrome: A randomized clinical trial
23. Fluvoxamine prevents recurrence of depression: Results of a long-term double-blind, placebo-controlled study
24. Martingale-based residuals for survival models